naltrexone has been researched along with bemesetron in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilsky, EJ; Delconte, JD; Hubbell, CL; Reid, LD | 1 |
Resta, JM; Resta, TC; Walker, BR | 1 |
Cuison, ER; Groseclose, CH; Kelley, BM; Middaugh, LD | 1 |
Aburada, M; Kase, Y; Murata, M; Omiya, Y; Suzuki, Y; Takeda, S; Yuzurihara, M | 1 |
4 other study(ies) available for naltrexone and bemesetron
Article | Year |
---|---|
MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Conditioning, Operant; Defecation; Ejaculation; Endorphins; Male; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Rats; Rats, Inbred Strains; Serotonin Antagonists; Tropanes; Urination | 1991 |
Role of endogenous opioids and serotonin in the hemodynamic response to hemorrhage during hypoxia.
Topics: Animals; Endorphins; Hemodynamics; Hemorrhage; Hypoxia; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Tropanes | 1995 |
Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice.
Topics: Animals; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Reinforcement, Psychology; Reward; Serotonin Antagonists; Tropanes | 2000 |
Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Combinations; Drugs, Chinese Herbal; Glycyrrhiza; Male; Medicine, Kampo; Methysergide; Mice; Naltrexone; Narcotic Antagonists; Oxidopamine; Paeonia; Pain Measurement; Pain Threshold; Piperazines; Serotonin Antagonists; Sympatholytics; Tropanes; Yohimbine | 2005 |